Tuesday broker round-up UPDATE

15th Jul 2014 08:53

Admiral Group: Numis moves target price from 1710p to 1720p, while downgrading from buy to add.African Barrick Gold: UBS initiates with a target price of 260p and a buy recommendation.Ashtead Group: Berenberg initiates with a target price of 1110p and a buy recommendation.British American Tabacco: Nomura reduces target price from 3700p to 3670p maintaining its buy recommendation.Cairn Energy: Goldman Sachs cuts target price from 250p to 229p and downgrades from buy to neutral.City of London Investment: Canaccord Genuity ups target price from 333p to 369p and stays with its buy recommendation.Debenhams: Investec upgrades from sell to hold with a target price of 62p.Drax: Credit Suisse ups target price from 750p to 805p and retains an outperform rating.GVC Holdings: Daniel Stewart increases target price to 505p and retains a buy recommendation.Hunting: Goldman Sachs reduces target price from 965p to 900p downgrading from buy to neutral.Informa: Berenberg cuts target price from 560p to 530p and reiterates a hold recommendation.Intertek Group: Deutsche Bank reduces target price from 2987p to 2694p, while retaining a hold recommendation.Kingfisher: UBS cuts target price from 470p to 450p and stays with its buy recommendation. Jefferies reduces target price from 480p to 450p reiterating a buy recommendation.Lloyds Banking Group: Deutsche Bank lowers target price from 90p to 87p and maintains a buy recommendation.Michael Page: Panmure Gordon upgrades from sell to hold with a target price of 399p. Canaccord Genuity raises target price from 400p to 500p and upgrades from hold to buy.Morgan Advanced Materials: Numis upgrades from reduce to hold with a target price of 300p.Next: Investec raises target price from 6700p to 7000p and keeps a hold recommendation.Old Mutual: UBS moves target price from 213p to 227p and upgrades from neutral to buy.Quindell: Canaccord Genuity reinstates with a target price of 362p and a buy recommendation.Sinclair IS Pharma: Canaccord Genuity shifts target price from 38p to 44p maintaining a buy recommendation.